G, S., & GW, O. (2015). Thymosin beta 4 ophthalmic solution for dry eye: A randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model. Dove Medical Press.
Chicago Style (17th ed.) CitationG, Sosne, and Ousler GW. Thymosin Beta 4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-controlled, Phase II Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model. Dove Medical Press, 2015.
MLA (8th ed.) CitationG, Sosne, and Ousler GW. Thymosin Beta 4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-controlled, Phase II Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model. Dove Medical Press, 2015.
Warning: These citations may not always be 100% accurate.